The main objective of the study is to describe function and health related to quality of life during the first year after rehabilitation, to measure the degree and impact of user involvement in the rehabilitation process, assess factors associated with change in work -ability and -participation, and to test measurement properties of a new core set of outcome measures for rehabilitation launched by the Norwegian Directorate of Health.
Eligibility
Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria:
* Patients that participates in inpatient or outpatient rehabilitation programs at one of the participating centers.
* Age over 18 years
* Access to internet at home
* Access to personal secure login with BANK ID.
Exclusion Criteria:
* Severely reduced cognitive function
* severe mental illness with inadequate consent competence ability to participate
* Insufficient understanding of Norwegian written language.
Primary outcome measure(s)
The EuroQoL-5D-5L — 1-3 minutes 5-item questionnaire assessing function and health in walking, ADL, personal care, pain/discomfort and anxiety/depression. Sores could be calculated both as numbers and 'utilities'.
The EuroQoL-VAS health — 1-2 minutes The EUROQUOL 5D-5L includes a 100 mm VAS scale/thermometer. Index value: 0-1, 1 is best VAS gen health: 0-100, 100 is best
The Patient Specific Functional Scale (PSFS) — 2-6 minutes Patient-specific instrument. Up to five activities are described by the patient, and scored according to experienced performance (0-10, 10 is best).
PROMIS 29 — 5-10 minutes The PROMIS-29, a generic health-related quality of life survey, assesses each of the 7 PROMIS domains (depression; anxiety; physical function; pain interference; fatigue; sleep disturbance; and ability to participate in social roles and activities) with 4 questions. The questions are ranked on a 5-point Likert Scale. There is also one 11-point rating scale for pain intensity.
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.
